The identification of irreversible rituximab-resistant lymphoma caused by CD20 gene mutations

C-terminal mutations of CD20 constitute part of the mechanisms that resist rituximab therapy. Most CD20 having a C-terminal mutation was not recognized by L26 antibody. As the exact epitope of L26 has not been determined, expression and localization of mutated CD20 have not been completely elucidate...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Mishima, Y, Terui, Y, Takeuchi, K, Matsumoto-Mishima, Y, Matsusaka, S, Utsubo-Kuniyoshi, R, Hatake, K
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2011
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3255244/
https://ncbi.nlm.nih.gov/pubmed/22829136
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2011.11
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller